home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

FDA/CMS Summit

 
  December 27, 2007  
     
 
Windhover Information Inc., Washington, DC
December 4-5, 2008


If you make FDA/CMS Summit an annual must-attend like hundreds of other pharmaceutical and biotech leaders, keep ahead of the curve and mark your calendars NOW.

Key Benefits for Attending FDA/CMS Summit:

  • Hear the critical trends and changes that affect your regulatory strategy successful strategies for dealing with FDA and CMS
  • Walk away with practical, real life lessons from some of the most experienced pharmaceutical and biotechnology executives on how they handle regulatory obstacles
  • Get face-to-face access to the top regulatory thought leaders and policy makers
  • Benchmark your regulatory strategy against all the major pharmaceutical and biotech companies

Hear the Regulators’ First-Hand Perspectives on:

  • User fees
  • Health care fraud prosecutions, especially in the new prescription drug benefit
  • Drug development and NDA approval strategies
  • Drug safety, risk management and post-market surveillance
  • Biogenerics/follow-on biologics
  • Personalized medicine
  • Pharma marketing and promotions regulation and enforcement
  • Marketing and promotion regulation and enforcement
  • Medicaid and Medicare reimbursement
  • Medicare Part D
  • Critical Path Initiative
  • Pricing Strategies
 
 
Organized by: Windhover Information Inc.
Invited Speakers: Please visit www.windhover.com/psa to view invited speakers.
 
Deadline for Abstracts: na
 
Registration: To register, please visit www.windhover.com/fda-cms
E-mail: ariley@windhover.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.